Keebeck Wealth Management, LLC Gilead Sciences, Inc. Transaction History

Keebeck Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $202,957 - $230,159	2,770 New	2,770 $224,000
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $147,573 - $211,864	2,368 New	2,368 $203,000
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $193,516 - $220,502	-3,416 Closed	0 $0
Q3 2020 Nov 02, 2020	BUY	$62.1 - $78.08 $63,528 - $79,875	1,023 Added 42.75%	3,416 $215,000
Q2 2020 Aug 06, 2020	BUY	$72.34 - $84.0 $173,109 - $201,012	2,393 New	2,393 $184,000
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $148,746 - $190,522	-2,375 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $146,347 - $160,977	2,375 New	2,375 $154,000

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Keebeck Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Keebeck Wealth Management, LLC with notifications on news.